Diabetes, Vol 43, Issue 3 459-467, Copyright © 1994 by American Diabetes Association

ARTICLES

Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay

JS Petersen, KR Hejnaes, A Moody, AE Karlsen, MO Marshall, M Hoier-Madsen, E Boel, BK Michelsen and T Dyrberg
Hagedorn Research Institute, Gentofte, Denmark.

Autoantibodies to glutamic acid decarboxylase (GAD) are frequent at or before the onset of insulin-dependent diabetes mellitus (IDDM). We have developed a simple, reproducible, and quantitative immunoprecipitation radioligand assay using as antigen in vitro transcribed and translated [35S]methionine-labeled human islet GAD65. By using this assay, 77% (77 of 100) of serum samples from recent-onset IDDM patients were positive for GAD65 antibodies compared with 4% (4 of 100) of serum samples from healthy control subjects. In competition analysis with unlabeled purified recombinant human islet GAD65, binding to tracer was inhibited in 74% (74 of 100) of the GAD65-positive IDDM serum samples compared with 2% of the control samples. The levels of GAD antibodies expressed as an index value relative to a standard serum, analyzed with or without competition, were almost identical (r = 0.991). The intra- and interassay variations of a positive control serum sample were 2.9 and 7.6%, respectively (n = 4). The frequency of GAD antibodies was significantly higher with IDDM onset before the age of 30 (80%, 59 of 74) than after the age of 30 (48%, 10 of 21) (P < 0.01). The prevalence of islet cell antibodies showed a similar pattern relative to age at onset. Because simultaneous occurrences of multiple autoimmune phenomena are common, we analyzed sera from patients with other autoimmune diseases. The frequency of GAD antibodies in sera positive for DNA autoantibodies (8% [2 of 25] and 4% [1 of 25] in competition analysis) or rheuma factor autoantibodies [12% (4 of 35) and 3% (1 of 35) in competition analysis] was not different from that in control samples. In contrast, in sera positive for ribonucleoprotein antibodies the frequency of GAD antibodies was significantly increased (73% [51 of 70] and 10% [7 of 70] in competition analysis [P < 0.025]). In conclusion, even large numbers of serum samples can now be tested for GAD65 antibodies in a relatively short time, allowing screening of individuals without a family history of IDDM for the presence of this marker.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A Mayer, N Fabien, M C Gutowski, V Dubois, L Gebuhrer, J Bienvenu, J Orgiazzi, and A M Madec Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adults Eur. J. Endocrinol., July 1, 2007; 157(1): 53 - 61. [Abstract] [Full Text] [PDF]

				R. P. Sahu, A. Aggarwal, G. Zaidi, A. Shah, K. Modi, S. Kongara, S. Aggarwal, S. Talwar, S. Chu, V. Bhatia, et al. Etiology of Early-Onset Type 2 Diabetes in Indians: Islet Autoimmunity and Mutations in Hepatocyte Nuclear Factor 1{alpha} and Mitochondrial Gene J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2462 - 2467. [Abstract] [Full Text] [PDF]

				M. Ankelo, A. Westerlund, K. Blomberg, M. Knip, J. Ilonen, and A. E. Hinkkanen Time-Resolved Immunofluorometric Dual-Label Assay for Simultaneous Detection of Autoantibodies to GAD65 and IA-2 in Children with Type 1 Diabetes Clin. Chem., March 1, 2007; 53(3): 472 - 479. [Abstract] [Full Text] [PDF]

				X LI, Z G ZHOU, G HUANG, X YAN, L YANG, X Y CHEN, and J P WANG Optimal Cutoff Point of Glutamate Decarboxylase Antibody Titers in Differentiating Two Subtypes of Adult-Onset Latent Autoimmune Diabetes Ann. N.Y. Acad. Sci., December 1, 2004; 1037(1): 122 - 126. [Abstract] [Full Text] [PDF]

				F. Skoldberg, F. Rorsman, J. Perheentupa, M. Landin-Olsson, E. S. Husebye, J. Gustafsson, and O. Kampe Analysis of Antibody Reactivity against Cysteine Sulfinic Acid Decarboxylase, A Pyridoxal Phosphate-Dependent Enzyme, in Endocrine Autoimmune Disease J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1636 - 1640. [Abstract] [Full Text] [PDF]

				A. KANUNGO and C. B. SANJEEVI IA-2 Autoantibodies Are Predominant in Latent Autoimmune Diabetes in Adults Patients from Eastern India Ann. N.Y. Acad. Sci., November 1, 2003; 1005(1): 390 - 394. [Abstract] [Full Text] [PDF]

				S. Mrena, K. Savola, P. Kulmala, H. Reijonen, J. Ilonen, H. K. Akerblom, and M. Knip Genetic Modification of Risk Assessment Based on Staging of Preclinical Type 1 Diabetes in Siblings of Affected Children J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2682 - 2689. [Abstract] [Full Text] [PDF]

				M. Ankelo, A. Westerlund-Karlsson, J. Ilonen, M. Knip, K. Savola, P. Kankaanpaa, L. Merio, H. Siitari, and A. Hinkkanen Time-resolved Fluorometric Assay for Detection of Autoantibodies to Glutamic Acid Decarboxylase (GAD65) Clin. Chem., June 1, 2003; 49(6): 908 - 915. [Abstract] [Full Text] [PDF]

				F. Skoldberg, G. M. Portela-Gomes, L. Grimelius, G. Nilsson, J. Perheentupa, C. Betterle, E. S. Husebye, J. Gustafsson, A. Ronnblom, F. Rorsman, et al. Histidine Decarboxylase, a Pyridoxal Phosphate-Dependent Enzyme, Is an Autoantigen of Gastric Enterochromaffin-Like Cells J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1445 - 1452. [Abstract] [Full Text] [PDF]

				A. Ramachandran, C. Snehalatha, K. Satyavani, S. Sivasankari, and V. Vijay Type 2 Diabetes in Asian-Indian Urban Children Diabetes Care, April 1, 2003; 26(4): 1022 - 1025. [Abstract] [Full Text] [PDF]

				S. Tanaka, K. Tatsumi, T. Tomita, M. Kimura, T. Takano, H. Yoshikawa, and N. Amino Novel autoantibodies to pituitary gland specific factor 1a in patients with rheumatoid arthritis Rheumatology, February 1, 2003; 42(2): 353 - 356. [Abstract] [Full Text] [PDF]

				A. KANUNGO, K. C. SAMAL, and C. B. SANJEEVI Molecular Mechanisms Involved in the Etiopathogenesis of Malnutrition-Modulated Diabetes Mellitus Ann. N.Y. Acad. Sci., April 1, 2002; 958(1): 138 - 143. [Abstract] [Full Text] [PDF]

				K. Savola, E. Laara, P. Vahasalo, P. Kulmala, H. K. Akerblom, and M. Knip Dynamic Pattern of Disease-Associated Autoantibodies in Siblings of Children With Type 1 Diabetes: A Population-Based Study Diabetes, November 1, 2001; 50(11): 2625 - 2632. [Abstract] [Full Text] [PDF]

				D. Osei-Hyiaman, L. Hou, R. Zhiyin, Z. Zhiming, H. Yu, A. A. Amankwah, and S. Harada Association of a Novel Point Mutation (C159G) of the CTLA4 Gene With Type 1 Diabetes in West Africans but not in Chinese Diabetes, September 1, 2001; 50(9): 2169 - 2171. [Abstract] [Full Text] [PDF]

				M.-B. Toft-Nielsen, M. B. Damholt, S. Madsbad, L. M. Hilsted, T. E. Hughes, B. K. Michelsen, and J. J. Holst Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3717 - 3723. [Abstract] [Full Text] [PDF]

				M.-B. Toft-Nielsen, S. Madsbad, and J. J. Holst Determinants of the Effectiveness of Glucagon-Like Peptide-1 in Type 2 Diabetes J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3853 - 3860. [Abstract] [Full Text] [PDF]

				A. M. Yamamoto, P. Gajdos, B. Eymard, C. Tranchant, J.-M. Warter, L. Gomez, C. Bourquin, J.-F. Bach, and H.-J. Garchon Anti-Titin Antibodies in Myasthenia Gravis: Tight Association With Thymoma and Heterogeneity of Nonthymoma Patients Arch Neurol, June 1, 2001; 58(6): 885 - 890. [Abstract] [Full Text] [PDF]

				A. Holz, T. Dyrberg, W. Hagopian, D. Homann, M. v. Herrath, and M. B. A. Oldstone Neither B Lymphocytes Nor Antibodies Directed Against Self Antigens of the Islets of Langerhans Are Required for Development of Virus-Induced Autoimmune Diabetes J. Immunol., November 15, 2000; 165(10): 5945 - 5953. [Abstract] [Full Text] [PDF]

				A.-M. HÄmäläinen, M. S. Ronkainen, H. K. Åkerblom, and M. Knip The Finnish TRIGR Study Group Postnatal Elimination of Transplacentally Acquired Disease-Associated Antibodies in Infants Born to Families with Type 1 Diabetes J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4249 - 4253. [Abstract] [Full Text]

				V. Jubault, A. Penfornis, F. Schillo, B. Hoen, M. Izembart, J. Timsit, M. D. Kazatchkine, J. Gilquin, and J.-P. Viard Sequential Occurrence of Thyroid Autoantibodies and Graves' Disease after Immune Restoration in Severely Immunocompromised Human Immunodeficiency Virus-1-Infected Patients J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4254 - 4257. [Abstract] [Full Text]

				M. R. Batstra, A. van Driel, J. S. Petersen, C. A. van Donselaar, M. J. van Tol, G. J. Bruining, D. E. Grobbee, T. Dyrberg, and H.-J. Aanstoot Glutamic Acid Decarboxylase Antibodies in Screening for Autoimmune Diabetes: Influence of Comorbidity, Age, and Sex on Specificity and Threshold Values Clin. Chem., December 1, 1999; 45(12): 2269 - 2272. [Full Text] [PDF]

				S. Mrena, K. Savola, P. Kulmala, H. K. Åkerblom, M. Knip, and the Childhood Diabetes in Finland Study Group Staging of Preclinical Type 1 Diabetes in Siblings of Affected Children Pediatrics, October 1, 1999; 104(4): 925 - 930. [Abstract] [Full Text]

				E. Sabbah, K. Savola, P. Kulmala, R. Veijola, P. Vähäsalo, J. Karjalainen, H. K. Åkerblom, and M. Knip Diabetes-Associated Autoantibodies in Relation to Clinical Characteristics and Natural Course in Children with Newly Diagnosed Type 1 Diabetes J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1534 - 1539. [Abstract] [Full Text]

				J. Tremble, N. G. Morgenthaler, A. Vlug, A. C. Powers, M. R. Christie, W. A. Scherbaum, and J. P. Banga Human B Cells Secreting Immunoglobulin G to Glutamic Acid Decarboxylase-65 from a Nondiabetic Patient with Multiple Autoantibodies and Graves' Disease: A Comparison with Those Present in Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2664 - 2670. [Abstract] [Full Text] [PDF]

				J. S Petersen, K. O Kyvik, P. J Bingley, E. A M Gale, A. Green, T. Dyrberg, and H. Beck-Nielsen Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus BMJ, May 31, 1997; 314(7094): 1575 - 1575. [Abstract] [Full Text]

				H. Tanaka, M. S. Perez, M. Powell, J. F. Sanders, J. Sawicka, S. Chen, L. Prentice, T. Asawa, C. Betterle, M. Volpato, et al. Steroid 21-Hydroxylase Autoantibodies: Measurements with a New Immunoprecipitation Assay J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1440 - 1446. [Abstract] [Full Text] [PDF]

				H. Borg, P. Fernlund, and G. Sundkvist Measurement of antibodies against glutamic acid decarboxylase 65 (GADA): two new 125I assays compared with [35S]GAD 65-ligand binding assay Clin. Chem., May 1, 1997; 43(5): 779 - 785. [Abstract] [Full Text] [PDF]

				L. Prentice, J. F. Sanders, M. Perez, R. Kato, J. Sawicka, Y. Oda, D. Jaskolski, J. Furmaniak, and B. R. Smith Thyrotropin (TSH) Receptor Autoantibodies Do Not Appear to Bind to the TSH Receptor Produced in an in Vitro Transcription/Translation System J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1288 - 1292. [Abstract] [Full Text] [PDF]